Hepatic benefits of sodium-glucose cotransporter 2 inhibitors in liver disorders

Diabetic patients are at higher risk of liver dysfunction compared with the normal population. Thus, using hypoglycemic agents to improve liver efficiency is important in these patients. Sodium-glucose cotransporters-2 inhibitors (SGLT2i) are newly developed antidiabetic drugs with potent glucose-lo...

Descripción completa

Detalles Bibliográficos
Autores principales: Yaribeygi, Habib, Maleki, Mina, Jamialahmadi, Tannaz, Moallem, Seyed Adel, Sahebkar, Amirhossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Leibniz Research Centre for Working Environment and Human Factors 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10279968/
https://www.ncbi.nlm.nih.gov/pubmed/37346806
http://dx.doi.org/10.17179/excli2023-6022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10279968/
https://www.ncbi.nlm.nih.gov/pubmed/37346806
http://dx.doi.org/10.17179/excli2023-6022

Ejemplares similares